Brief: Takara Holdings' subsidiary Takara Bio says merger between US-based units
27/03/2017 07:19
March 27 (Reuters) - Takara Bio Inc 4974.T :
* Says the company's wholly owned US-based sub-subsidiary
Takara Bio USA Inc plans to merge with co's other two wholly
owned US-based sub-subsidiaries Rubicon Genomics Inc and
WaferGen Bio-systems Inc, with effective date on March 31 (for
Rubicon) and May 31 (for WaferGen)respectively
* Says units Rubicon Genomics and WaferGen Bio-systems will
be dissolved after transaction
* Says the company, Takara Bio Inc, is a consolidated
subsidiary of Takara Holdings Inc 2531.T
Source text in Japanese: https://goo.gl/lUD7Ey ;
https://goo.gl/l13Gch
Further company coverage: 4974.T 2531.T
(Beijing Headline News)
((Beijing.HeadlineNews@thomsonreuters.com; +86 62674724;
Reuters Messaging: Cheng.Li@thomsonreuters.com@reuters.net))